This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pharma Clinical Trial Services: World Market 2013-2023

Table 4.6 Western European Clinical Trial Services Market: Revenue Forecasts by Country, 2011-2023

Table 4.7 German Clinical Trial Services Market Forecast, 2011-2023

Table 4.8 French Clinical Trial Services Market Forecast, 2011-2023

Table 4.9 UK Clinical Trial Services Market Forecast, 2011-2023

Table 4.10 Italian Clinical Trial Services Market Forecast, 2011-2023

Table 4.11 Spanish Clinical Trial Services Market Forecast, 2011-2023

Table 4.12 Japanese Clinical Trial Services Market Forecast, 2011-2023

Table 5.1 Leading Emerging Markets for Pharma Clinical Trial Services, 2011

Table 5.2 Population Statistics in BRIC Nations, 2012

Table 5.3 Relative Competence in English in Emerging Markets, 2012

Table 5.4 Pharma Clinical Trial Services Market: Revenue Forecasts in Emerging Markets, 2011-2023

Table 5.5 Indian Clinical Trial Services Market Forecast, 2011-2023

Table 5.6 Chinese Clinical Trial Services Market Forecast, 2011-2023

Table 5.7 South Korean Clinical Trial Services Market Forecast, 2011-2023

Table 5.8 Russian Clinical Trial Services Market Forecast, 2011-2023

Table 5.9 CEE Clinical Trial Services Market Forecast, 2011-2023

Table 5.10 Brazilian Clinical Trial Services Market Forecast, 2011-2023

Table 6.1 Global Clinical Trials by Therapeutic Area, 2012

Table 6.2 Leading Therapeutic Areas for Clinical Trial Services, 2011

Table 6.3 Clinical Pipelines for Leading Therapeutic Areas, 2010-2012

Table 6.4 Pharma Clinical Trial Services Market: Revenue Forecasts for Leading Therapeutic Areas, 2011-2023

Table 6.5 Leading CROs Specialising in Biomarker Services, 2012

Table 6.6 Cancer Clinical Trial Services Submarket: Drivers and Restraints, 2011-2023

Table 6.7 Cancer Clinical Trial Services Submarket Forecast, 2011-2023

Table 6.8 Late-Stage Pipeline Failures in Alzheimer's Disease, 2009-2012

Table 6.9 CNS Disease Clinical Trial Services Submarket: Drivers and Restraints, 2011-2023

Table 6.10 CNS Disease Clinical Trial Services Submarket Forecast, 2011-2023

Table 6.11 Cardiovascular Disease Clinical Trial Services Submarket Forecast, 2011-2023

Table 6.12 Cardiovascular Disease Clinical Trial Services Submarket: Drivers and Restraints, 2011-2023

Table 6.13 Chronic Hepatitis B & C: Global Prevalence by Region, 2012

Table 6.14 Infectious Disease Clinical Trial Services Submarket Forecast, 2011-2023

8 of 13

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,097.36 +73.30 0.41%
S&P 500 2,116.63 +8.34 0.40%
NASDAQ 5,027.0720 +21.6810 0.43%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs